APA

Li Y., Zhang J., Zhou Q., Wang H., Xie S., Yang X., Ji P., Zhang W., He T., Liu Y., Wang K., Li X., Shi J. & Hu D. (20200617). Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. : Experimental dermatology.

Chicago

Li Yan, Zhang Julei, Zhou Qin, Wang Hongtao, Xie Songtao, Yang Xuekang, Ji Peng, Zhang Wanfu, He Ting, Liu Yang, Wang Kejia, Li Xiaoqiang, Shi Jihong and Hu Dahai. 20200617. Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. : Experimental dermatology.

Harvard

Li Y., Zhang J., Zhou Q., Wang H., Xie S., Yang X., Ji P., Zhang W., He T., Liu Y., Wang K., Li X., Shi J. and Hu D. (20200617). Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. : Experimental dermatology.

MLA

Li Yan, Zhang Julei, Zhou Qin, Wang Hongtao, Xie Songtao, Yang Xuekang, Ji Peng, Zhang Wanfu, He Ting, Liu Yang, Wang Kejia, Li Xiaoqiang, Shi Jihong and Hu Dahai. Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. : Experimental dermatology. 20200617.